Literature DB >> 1562737

Inhibition of c-jun causes reversible proliferative arrest and withdrawal from the cell cycle.

M J Smith1, E V Prochownik.   

Abstract

We studied the effect of c-jun depletion in Friend murine erythroleukemia (F-MEL) cells stably transfected with a plasmid that allowed for the glucocorticoid-mediated conditional expression of c-jun antisense sequences. The c-jun cDNA used for the construction of the vector was modified so as to prevent the nonspecific targeting of junB and junD transcripts. High level and rapid induction of c-jun antisense transcripts was achieved with as little as 10(-8) mol/L dexamethasone (DEX) and resulted in a 80% to 90% reduction in c-jun protein levels. The continuous exposure of the transfected cells to DEX inhibited growth by greater than 85% over a 5-day period, whereas DEX had no effect on the growth rate of control F-MEL cells. This proliferative block was associated with a reversible accumulation of cells with a 2n DNA content. When these cells were recultured in the absence of DEX, c-jun protein rapidly reappeared and the immediate early response genes egr-1, junB, and c-myc were transiently expressed. Thus, inhibition of c-jun protein causes logarithmically growing cells to leave the cell cycle and to enter a state closely resembling, if not identical to, G0. These results underscore the importance of c-jun in maintaining cellular proliferation and provide additional evidence for the participation of proto-oncogenes in cell cycle control.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1562737

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

Review 1.  AP-1 and colorectal cancer.

Authors:  Reiko Ashida; Kazunari Tominaga; Eiji Sasaki; Toshio Watanabe; Yasuhiro Fujiwara; Nobuhide Oshitani; Kazuhide Higuchi; Shokei Mitsuyama; Hiroshi Iwao; Tetsuo Arakawa
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

2.  Induction of AP-1 activity associated with c-Jun and JunB is required for mitogenesis induced by insulin and vanadate in SV40-transformed 3T3T cells.

Authors:  H Wang; Z Xie; R E Scott
Journal:  Mol Cell Biochem       Date:  1997-03       Impact factor: 3.396

3.  v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity.

Authors:  W Clark; E J Black; A MacLaren; U Kruse; N LaThangue; P K Vogt; D A Gillespie
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

4.  Control of cell cycle progression by c-Jun is p53 dependent.

Authors:  M Schreiber; A Kolbus; F Piu; A Szabowski; U Möhle-Steinlein; J Tian; M Karin; P Angel; E F Wagner
Journal:  Genes Dev       Date:  1999-03-01       Impact factor: 11.361

5.  STRAP regulates c-Jun ubiquitin-mediated proteolysis and cellular proliferation.

Authors:  Jennifer Reiner; Fei Ye; Nilesh D Kashikar; Pran K Datta
Journal:  Biochem Biophys Res Commun       Date:  2011-03-21       Impact factor: 3.575

6.  Adipocyte differentiation selectively represses the serum inducibility of c-jun and junB by reversible transcription-dependent mechanisms.

Authors:  H Wang; R E Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

7.  Existence of different Fos/Jun complexes during the G0-to-G1 transition and during exponential growth in mouse fibroblasts: differential role of Fos proteins.

Authors:  K Kovary; R Bravo
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

8.  Differential patterns of DNA binding by myc and max proteins.

Authors:  E V Prochownik; M E VanAntwerp
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

9.  Integrin alpha 5 beta 1 expression negatively regulates cell growth: reversal by attachment to fibronectin.

Authors:  J A Varner; D A Emerson; R L Juliano
Journal:  Mol Biol Cell       Date:  1995-06       Impact factor: 4.138

10.  Regulation of the glucocorticoid receptor gene by the AP-1 transcription factor.

Authors:  P Wei; W V Vedeckis
Journal:  Endocrine       Date:  1997-12       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.